Ginseng (Panax) for Anti-Inflammatory

Research suggests that Panax ginseng and its active compounds, particularly ginsenosides, possess meaningful anti-inflammatory properties across a range of experimental models, with evidence pointing to suppression of key inflammatory signaling pathways including NF-κB, MAPK, and inflammasome activation, as well as reductions in pro-inflammatory cytokines, nitric oxide, and reactive oxygen species. Studies indicate these effects extend to multiple ginseng fractions beyond the root, including berry calyx, stems, leaves, and polysaccharides, suggesting the anti-inflammatory activity is distributed across the plant rather than confined to a single compound or extract. The body of evidence reviewed here is composed predominantly of cell-based laboratory experiments and animal studies, along with a number of narrative reviews synthesizing preclinical findings, with very limited representation from randomized controlled trials or large-scale human clinical research. This means that while the mechanistic picture is reasonably well-developed at the preclinical level, it remains uncertain how consistently or meaningfully these effects translate to humans, and the current evidence base does not yet support definitive conclusions about efficacy in clinical settings.